Literature DB >> 2553780

Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation.

B L Gruber1, M J Marchese, K Suzuki, L B Schwartz, Y Okada, H Nagase, N S Ramamurthy.   

Abstract

Mast cells have been implicated in the pathogenesis of the matrix degradation observed in the cartilaginous and osseous structures of the rheumatoid joint. We previously reported that human mast cell tryptase, a 134-kD granule-associated neutral protease, is present in rheumatoid synovium and can activate collagenase in crude culture medium in vitro. the present study attempts to depict the precise mechanism of this activation. To express full activation of latent collagenase, matrix metalloproteinase 3 (MMP-3) or stromelysin, can be activated by tryptase in a time and dose-dependent manner. Tryptase was not capable of generating active collagenase in the crude media from cultured rheumatoid synoviocytes depleted of proMMP-3 by immunoadsorption. In addition, the function of the tissue inhibitor of metalloproteinases (TIMP) was not altered by tryptase, and SDS-PAGE analysis revealed no degradation of TIMP by tryptase. The tryptase dependent activation of synoviocyte procollagenase thereby appears to be entirely dependent upon its ability to activate proMMP-3.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2553780      PMCID: PMC304033          DOI: 10.1172/JCI114344

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

Review 1.  Recent insights into the pathogenesis of the proliferative lesion in rheumatoid arthritis.

Authors:  E D Harris
Journal:  Arthritis Rheum       Date:  1976 Jan-Feb

2.  Neutral metallo-proteinases of rabbit bone. Separation in latent forms of distinct enzymes that when activated degrade collagen, gelatin and proteoglycans.

Authors:  A Sellers; J J Reynolds; M C Meikle
Journal:  Biochem J       Date:  1978-05-01       Impact factor: 3.857

3.  Characterization and functional studies of rheumatoid synovial mast cells. Activation by secretagogues, anti-IgE, and a histamine-releasing lymphokine.

Authors:  B Gruber; M Poznansky; E Boss; J Partin; P Gorevic; A P Kaplan
Journal:  Arthritis Rheum       Date:  1986-08

4.  Degradation of type IX collagen by matrix metalloproteinase 3 (stromelysin) from human rheumatoid synovial cells.

Authors:  Y Okada; H Konomi; T Yada; K Kimata; H Nagase
Journal:  FEBS Lett       Date:  1989-02-27       Impact factor: 4.124

5.  Treatment of periodontal disease in beagles with lodoxamide ethyl, an inhibitor of mast cell release.

Authors:  M K Jeffcoat; R C Williams; H G Johnson; W J Wechter; P Goldhaber
Journal:  J Periodontal Res       Date:  1985-09       Impact factor: 4.419

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Degradation of basement membranes by human matrix metalloproteinase 3 (stromelysin).

Authors:  P A Bejarano; M E Noelken; K Suzuki; B G Hudson; H Nagase
Journal:  Biochem J       Date:  1988-12-01       Impact factor: 3.857

8.  Evidence that human rheumatoid synovial matrix metalloproteinase 3 is an endogenous activator of procollagenase.

Authors:  A Ito; H Nagase
Journal:  Arch Biochem Biophys       Date:  1988-11-15       Impact factor: 4.013

9.  A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots.

Authors:  M S Blake; K H Johnston; G J Russell-Jones; E C Gotschlich
Journal:  Anal Biochem       Date:  1984-01       Impact factor: 3.365

10.  Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis?

Authors:  R A Hawkins; H N Claman; R A Clark; J C Steigerwald
Journal:  Ann Intern Med       Date:  1985-02       Impact factor: 25.391

View more
  62 in total

1.  The structure of the human betaII-tryptase tetramer: fo(u)r better or worse.

Authors:  C P Sommerhoff; W Bode; P J Pereira; M T Stubbs; J Stürzebecher; G P Piechottka; G Matschiner; A Bergner
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

Review 2.  The diverse effects of mast cell mediators.

Authors:  Colleen Hines
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

Review 3.  Cardiac mast cells: the centrepiece in adverse myocardial remodelling.

Authors:  Scott P Levick; Giselle C Meléndez; Eric Plante; Jennifer L McLarty; Gregory L Brower; Joseph S Janicki
Journal:  Cardiovasc Res       Date:  2010-08-24       Impact factor: 10.787

Review 4.  Kounis syndrome (allergic acute coronary syndrome): different views in allergologic and cardiologic literature.

Authors:  Filippo Fassio; Fabio Almerigogna
Journal:  Intern Emerg Med       Date:  2012-01-22       Impact factor: 3.397

5.  Mast cell tryptase deficiency attenuates mouse abdominal aortic aneurysm formation.

Authors:  Jie Zhang; Jiusong Sun; Jes S Lindholt; Galina K Sukhova; Mark Sinnamon; Richard L Stevens; Roberto Adachi; Peter Libby; Robert W Thompson; Guo-Ping Shi
Journal:  Circ Res       Date:  2011-04-14       Impact factor: 17.367

Review 6.  Mast cell tryptases and chymases in inflammation and host defense.

Authors:  George H Caughey
Journal:  Immunol Rev       Date:  2007-06       Impact factor: 12.988

Review 7.  Regulation and function of mast cell proteases in inflammation.

Authors:  C Huang; A Sali; R L Stevens
Journal:  J Clin Immunol       Date:  1998-05       Impact factor: 8.317

8.  Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts.

Authors:  J A Cairns; A F Walls
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

Review 9.  Mast cell chymase and tryptase in abdominal aortic aneurysm formation.

Authors:  Yi Wang; Guo-Ping Shi
Journal:  Trends Cardiovasc Med       Date:  2012-08-14       Impact factor: 6.677

10.  Mast cells: pivotal players in cardiovascular diseases.

Authors:  Ilze Bot; Theo J C van Berkel; Erik A L Biessen
Journal:  Curr Cardiol Rev       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.